Coronary vulnerable plaque is associated with adverse cardiovascular events in patients with coronary atherosclerotic heart disease. The development of intravascular imaging has provided a new perspective on the biological factors of the development of atherosclerotic plaques. By identifying the imaging features most likely to lead to adverse cardiovascular events, it can timely identify high-risk patients in clinic, and carry out active prevention and treatment, so as to improve the patients’ life quality.